Annexin Pharmaceuticals AB (publ) (ANNX.ST)

SEK 0.43

(-1.61%)

Annual Balance Sheets

(In SEK)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 26.76 Million 36.67 Million 52.78 Million 25.15 Million 16.03 Million 46.03 Million
Total Current Assets 24.91 Million 33.65 Million 50.71 Million 22.89 Million 13.67 Million 43.48 Million
Cash And Short Term Investments 21.41 Million 31.11 Million 49.47 Million 18.13 Million 4.26 Million 30.21 Million
Cash and Cash Equivalents 21.41 Million 31.11 Million 49.47 Million 18.13 Million 4.26 Million 30.21 Million
Short Term Investments - - - - - -
Net Receivables 2.63 Million 1.86 Million 1.01 Million 282 Thousand 266 Thousand 614 Thousand
Inventory - - 1.00 4280.00 8561.00 12.59 Million
Other Current Assets 867 Thousand 674 Thousand 223 Thousand 4.48 Million 9.14 Million 13.27 Million
Total Non-Current Assets 1.84 Million 3.02 Million 2.06 Million 2.26 Million 2.35 Million 2.55 Million
Net PPE 1.16 Million 1.25 Million 1.34 Million 1.43 Million 1.52 Million 1.61 Million
Good Will And Intangible Assets 371 Thousand 474 Thousand 577 Thousand 680 Thousand 783 Thousand 887 Thousand
Good Will - - - - - -
Intangible Assets 371 Thousand 474 Thousand 577 Thousand 680 Thousand 783 Thousand 887 Thousand
Long-Term Investments 311 Thousand 407 Thousand 146 Thousand 146 Thousand 50 Thousand 50 Thousand
Tax Assets -311 Thousand -407 Thousand -146 Thousand -146 Thousand -50 Thousand -50 Thousand
Other Non Current Assets 311 Thousand 1.29 Million 146 Thousand 146 Thousand 50 Thousand 49 Thousand
Other Assets -0.00 - - -0.00 0.00 -
Total Liabilities 7.94 Million 6.52 Million 6.05 Million 4.52 Million 4.54 Million 6.18 Million
Total Current Liabilities 7.94 Million 6.52 Million 6.05 Million 4.52 Million 4.54 Million 5.95 Million
Account Payables 4.32 Million 3.32 Million 3.51 Million 2.9 Million 2.4 Million 3.14 Million
Tax Payables - - - - - -
Short Term Debt - - - - 227 Thousand 250 Thousand
Deferred Revenue - - - - 1.52 Million 1.39 Million
Other Current Liabilities 3.62 Million 3.19 Million 2.54 Million 1.62 Million 387 Thousand 1.16 Million
Total Non Current Liabilities - 3.32 Million - - - 229 Thousand
Long-Term Debt - - - - - 229 Thousand
Deferred Revenue Non Current - - - - - -
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities - 3.32 Million - - - -
Other Liabilities - -3.32 Million - - - -
Total Equity 18.81 Million 30.15 Million 46.72 Million 20.63 Million 11.48 Million 39.85 Million
Stock Holders Equity 18.81 Million 30.15 Million 46.72 Million 20.63 Million 11.48 Million 39.85 Million
Common Stock 5.73 Million 2.67 Million 27.44 Million 21.22 Million 17.68 Million 17.68 Million
Retained Earnings -286.21 Million -242.15 Million -201.63 Million -149.48 Million -105.24 Million -76.88 Million
Accumulated other comprehensive income - 122.00 - - 1.00 -
Common Stock Equity 18.81 Million 30.15 Million 46.72 Million 20.63 Million 11.48 Million 39.85 Million
Capital Lease Obligation - - - - - -
Total Investments 311 Thousand 407 Thousand 146 Thousand 146 Thousand 50 Thousand 50 Thousand
Total Debt - - - - 227 Thousand 479 Thousand
Net Debt -21.41 Million -31.11 Million -49.47 Million -18.13 Million -4.03 Million -29.73 Million

Balance Sheet Charts